Table 1.
Group 1 (controls, n=15) | Group 2 (Endometriosis, n=30) | p-value | |
---|---|---|---|
Serum apelin ( pg/ml ) | |||
proliferative phase | 711±122 | 731±124 | 0.97 |
secretory phase | 703±124 | 735±114 | 0.86 |
p-value | NS | NS | |
| |||
Eutopic endometrial apelin ( pg/mg ) | |||
proliferative phase | 1317±299 | 1094±287 | 0.08 |
secretory phase | 2499±208 | 2418±191 | 0.51 |
p-value | |||
SPP vs. EuPP | <0.05 | <0.05 | -- |
SSP vs. EuSP | <0.05 | <0.05 | -- |
| |||
Ectopic endometrial apelin ( pg/mg ) | |||
proliferative phase | -- | 1189±134 | -- |
secretory phase | -- | 2639±342 | -- |
p-value | -- | -- | -- |
EuPP vs. EcPP | -- | NS | -- |
EuSP vs. EcSP | -- | NS | -- |
Note: The results were presented as mean±SD. SPP=serum proliferative phase; SSP=serum secretory phase;
EuPP=eutopic proliferative phase; EcPP=ectopic proliferative phase; EuSP=Eutopic secretory phase;
EcSP=ectopic secretory phase.
NS=Not significant